Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NDUFA5P3 is a pseudogene and not a functional gene product. Although it shares sequence similarity with the protein-coding gene NDUFA5, it does not encode a functional protein and thus does not participate in mitochondrial respiration or electron transport. Pseudogenes are generally considered genomic relics with no known biological function, product, or therapeutic relevance. There are multiple similar pseudogenes on various chromosomes. No evidence exists linking NDUFA5P3 directly to disease, drug targeting, biomarker status, or clinical safety concern[4][10]. If you are seeking a mitochondrial complex I subunit relevant as a therapeutic or biological target, the correct gene would be NDUFA5 (NADH:ubiquinone oxidoreductase subunit A5), not NDUFA5P3[1][3][12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit A5 pseudogene 3 (NDUFA5P3).